miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1, Published online: 22 July 2018; doi:10.1038/s41417-018-0035-0miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
Source: Cancer Gene Therapy - Category: Cancer & Oncology Authors: Dawei Wu Jun Zhang Ying Lu Song Bo Lianhong Li Lu Wang Qingqing Zhang Jun Mao Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Gene Therapy | Genetics | Stem Cell Therapy | Stem Cells